necessity of impairment testing of assets
what is mean by assets register?
7AS 3b seSUDtirTe'pfinciples and methodolgy for accounting for impairments of non-current assets and goodwill. Where possible individual non-current assets should be tested for impairment, ver
Goodwill is typically found on the balance sheet under the non-current assets section, specifically listed after intangible assets. It represents the excess amount paid during an acquisition over the fair value of the identifiable net assets acquired. If a company has multiple intangible assets, goodwill will usually be listed separately to provide clarity on its valuation. It is important to monitor goodwill regularly, as it may be subject to impairment testing.
The purpose of impairment of assets is to ensure that an organization's financial statements reflect the true value of its assets. When an asset's carrying amount exceeds its recoverable amount, it indicates a decrease in value, necessitating a write-down to avoid overstating the asset's worth. This process helps maintain accurate financial reporting, supports informed decision-making, and upholds compliance with accounting standards. By recognizing impairment, companies can provide a clearer picture of their financial health to stakeholders.
It's not. If inventory or assets have become impaired the impairment amount gets written off as an expense to the profit and loss. With fixed assets this normally happens when they are revalued.
I believe they should, so that medication doses can be adjusted for renal impairment.
Goodwill is capitalized when a company acquires another business for a price higher than the fair value of its identifiable assets and liabilities. In accounting, goodwill represents the intangible value of a company's reputation, customer relationships, and other non-physical assets. It is recorded as an asset on the balance sheet and subject to annual impairment testing.
Goodwill is not depreciated in the traditional sense, as it is considered an intangible asset with an indefinite useful life. Instead, it is tested for impairment at least annually or more frequently if there are indicators of potential impairment. If the carrying value of goodwill exceeds its fair value, an impairment loss is recognized, but it does not undergo systematic depreciation like tangible assets.
When assets are recorded a company's balance sheet, they are valued at historical cost (what was paid for the asset), less any accumulated depreciation or amortization if applicable. This holds true even if the market value of the asset is considerably more than what the company paid for it. However, if the market value of a company's assets drops significantly below the asset's historical cost, then it sometimes becomes necessary to revalue the asset at the lower market value. This revaluation is called impairment. When it is appropriate to impair an asset depends on the type of asset in question. The difference between the current book value of the asset, and the value of the asset after impairment, is your impairment expense (cost).
Mergers are accounted for using the acquisition method, which involves identifying the acquirer, determining the acquisition date, and recognizing the identifiable assets acquired and liabilities assumed at their fair values. Any excess of the purchase price over the fair value of net identifiable assets is recorded as goodwill. Financial statements must reflect these adjustments, and disclosures are required to provide information about the merger's impact on the financial position and results of operations. Additionally, subsequent reporting periods may require impairment testing for goodwill and other intangible assets.
Answer - Goodwill impairment occurs when the value of the goodwill of a business unit declines to an amount less than the carrying value of the goodwill on the company's books. With the adoption of SFAS 142 by the Financial Accounting Standards Board (FASB), audited companies are now required to test goodwill annually for impairment. This testing is done by valuing the business unit having the goodwill.
BCBSFL will cover certain diagnostic codes billed for pharmacological DNA testing, but will deny codes 81226,81227, & G9143 on the basis of medical necessity.